336 related articles for article (PubMed ID: 17948274)
21. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
[TBL] [Abstract][Full Text] [Related]
22. COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells.
Jung ID; Jeong YI; Lee CM; Noh KT; Jeong SK; Chun SH; Choi OH; Park WS; Han J; Shin YK; Kim HW; Yun CH; Park YM
Int Immunopharmacol; 2010 Jul; 10(7):760-8. PubMed ID: 20399909
[TBL] [Abstract][Full Text] [Related]
23. Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase.
Lanzinger M; Jürgens B; Hainz U; Dillinger B; Raberger J; Fuchs D; Heitger A
Eur J Immunol; 2012 May; 42(5):1117-28. PubMed ID: 22539287
[TBL] [Abstract][Full Text] [Related]
24. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
[TBL] [Abstract][Full Text] [Related]
25. Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines.
Hwang SL; Chung NP; Chan JK; Lin CL
Cell Res; 2005 Mar; 15(3):167-75. PubMed ID: 15780178
[TBL] [Abstract][Full Text] [Related]
26. Indoleamine 2,3-dioxygenase expression and functional activity in dendritic cells exposed to cholera toxin.
Slavica L; Nurkkala-Karlsson M; Karlson T; Ingelsten M; Nyström J; Eriksson K
Scand J Immunol; 2012 Aug; 76(2):113-22. PubMed ID: 22519828
[TBL] [Abstract][Full Text] [Related]
27. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.
Jürgens B; Hainz U; Fuchs D; Felzmann T; Heitger A
Blood; 2009 Oct; 114(15):3235-43. PubMed ID: 19625705
[TBL] [Abstract][Full Text] [Related]
28. Indoleamine 2,3-dioxygenase in transplantation.
Mulley WR; Nikolic-Paterson DJ
Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
[TBL] [Abstract][Full Text] [Related]
29. Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells.
Li L; Li SP; Min J; Zheng L
Immunol Lett; 2007 Nov; 114(1):38-45. PubMed ID: 17945351
[TBL] [Abstract][Full Text] [Related]
30. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
Abediankenari S; Ghasemi M
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
[TBL] [Abstract][Full Text] [Related]
31. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
32. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C; Grohmann U
Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
[TBL] [Abstract][Full Text] [Related]
33. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.
Puccetti P; Fallarino F
Blood Cells Mol Dis; 2008; 40(1):101-5. PubMed ID: 17881253
[TBL] [Abstract][Full Text] [Related]
34. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK
J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533
[TBL] [Abstract][Full Text] [Related]
36. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
37. IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive.
Godin-Ethier J; Hanafi LA; Duvignaud JB; Leclerc D; Lapointe R
Mol Immunol; 2011 Oct; 49(1-2):253-9. PubMed ID: 21937116
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization.
Tas SW; de Jong EC; Hajji N; May MJ; Ghosh S; Vervoordeldonk MJ; Tak PP
Eur J Immunol; 2005 Apr; 35(4):1164-74. PubMed ID: 15770694
[TBL] [Abstract][Full Text] [Related]
39. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells.
Jenner J; Kerst G; Handgretinger R; Müller I
Exp Hematol; 2006 Sep; 34(9):1212-8. PubMed ID: 16939814
[TBL] [Abstract][Full Text] [Related]
40. Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation.
D'Ambrosio A; Colucci M; Pugliese O; Quintieri F; Boirivant M
J Leukoc Biol; 2008 Sep; 84(3):661-8. PubMed ID: 18562485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
